Photocross-linked
alginate hydrogels, due to their biodegradability,
biocompatibility, strong control for gelling kinetics in space and
time, and admirable adaptability for in situ polymerization with a
minimally invasive approach in surgical procedures, have created great
expectations in bone regeneration. However, hydrogels with suitable
degradation kinetics that can match the tissue regeneration process
have not been designed, which limits their further application in
bone tissue engineering. Herein, we finely developed an oxidation
strategy for alginate to obtain hydrogels with more suitable degradation
rates and comprehensively explored their physical and biological performances
in vitro and in vivo to further advance the clinical application for
the hydrogels in bone repair. The physical properties of the gels
can be tuned via tailoring the degree of alginate oxidation. In particular,
in vivo degradation studies showed that the degradation rates of the
gels were significantly increased by oxidizing alginate. The activity,
proliferation, initial adhesion, and osteogenic differentiation of
rat and rabbit bone marrow stromal cells (BMSCs) cultured with/in
the hydrogels were explored, and the results demonstrated that the
gels possessed excellent biocompatibility and that the encapsulated
BMSCs were capable of osteogenic differentiation. Furthermore, in
vivo implantation of rabbit BMSC-loaded gels into tibial plateau defects
of rabbits demonstrated the feasibility of hydrogels with appropriate
degradation rates for bone repair. This study indicated that hydrogels
with increasingly controllable and matchable degradation kinetics
and satisfactory bioproperties demonstrate great clinical potential
in bone tissue engineering and regenerative medicine and could also
provide references for drug/growth-factor delivery therapeutic strategies
for diseases requiring specific drug/growth-factor durations of action.